tirzepatide compound fda lawsuit Compounders lose battle over Eli Lilly weight loss drug and shortage list Weight loss drug lawsuit: Mounjaro

Eli Lilly's tirzepatide medications, including Zepbound and diabetes drug Mounjaro, are competitors to Novo Nordisk's semaglutide drugs Ozempic and Wegovy

If you are considering splitting your dose, the article on splitting tirzepatide into twice-weekly injections covers the practicalities and considerations

But "can" and "should" are different questions

How tirzepatide is discontinued matters for certain research endpoints

The more comprehensive the documentation package, the stronger the prior authorization submission

If the 5.0mg [tirzepatide] is the same cost as 1.0mg Ozempic, then I would imagine [tirzepatide] 5.0mg would be used in preference to Ozempic. Beba highlighted that tirzepatide is still awaiting results from a cardiovascular outcome trial SURPASS-CVOT, due late 2024 which may influence recommendations